Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Molecular Neuroscience|October 26, 2020
Tau Protein and Its Role in Blood-Brain Barrier DysfunctionAlena Michalicova, Petra Majerova, Andrej KovacGeneral Physiology and Biophysics|December 13, 2021
Pathophysiology of the choroid plexus in brain diseasesSandra Mihaljevic, Alena Michalicova, Mangesh Bhide, et al.Journal of Chromatographic Science|December 4, 2014
Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Homocysteine in Rat Plasma: Application to the Study of a Rat Model for TauopathiesAndrej Kovac, Katarina Svihlova, Alena Michalicova, et al.Current Alzheimer Research|February 7, 2017
Tauopathies - Focus on Changes at the Neurovascular UnitAlena Michalicova, William A Banks, Jaroslav Legath, et al.Journal of Pharmaceutical and Biomedical Analysis|September 8, 2015
Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detectionJaroslav Galba, Alena Michalicova, Vojtech Parrak, et al.Journal of Alzheimer'S Disease : JAD|April 29, 2017
Changes of Cerebrospinal Fluid Peptides due to TauopathyPetra Majerova, Peter Barath, Alena Michalicova, et al.Neurological Research|April 6, 2018
Dynamics of Evans blue clearance from cerebrospinal fluid into meningeal lymphatic vessels and deep cervical lymph nodesMarcela Maloveska, Jan Danko, Eva Petrovova, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 17, 2022
Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathyPetra Majerova, Dominika Olesova, Greta Golisova, et al.Plos One|May 24, 2019
Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathiesPetra Majerova, Alena Michalicova, Martin Cente, et al.Pageof 1